Please login to the form below

Not currently logged in
Email:
Password:

Merck acquires Amnis Corporation

Merck's Millipore division is to acquire Amnis Corporation, a US-based manufacturer of cell imaging systems

Merck Millipore, known as EMD Millipore in the US and Canada, is to acquire Amnis Corporation, a US-based manufacturer of cell imaging systems.

Merck Millipore is the life sciences division of German pharmaceutical firm Merck.

The transaction is expected to take place before the end of 2011 according to Amnis, with financial terms undisclosed.

Amnis had revenue of $14m (€10m) in 2010 developing, manufacturing and marketing tools for high speed cell imaging for research and diagnostic markets.

Jonathan DiVincenzo, head of the bioscience business unit within Merck Millipore said: "The acquisition of Amnis significantly contributes to our strategy to be a leader in cellular analysis and systems biology."

David A Basiji, co-founder and CEO of Amnis said: "The combination of Amnis with EMD Millipore will greatly accelerate development of novel applications in imaging flow cytometry, enhance our customer support, and accelerate product development."

30th August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Media

Four Health Media creates world class integrated media solutions with global reach, deep insight, innovative methods and a highly personal...

Latest intelligence

Finding the patient voice
How patients feel and speak about clinical trials...
Six Factors to Consider When Designing Advisory Boards
...
The good, the bad and the ugly
Tracking the pharmaceutical industry’s 2017 evolution and assessing how things may shape up in 2018 - it’s a trilogy of trends...

Infographics